Lavipharm S.A. (LAVI.AT)

EUR 0.75

(3.15%)

EBITDA Summary of Lavipharm S.A.

Lavipharm S.A.'s latest annual EBITDA in 2023 was 9.86 Million EUR , up 89.94% from previous year.
Lavipharm S.A.'s latest quarterly EBITDA in 2024 Q2 was 5.68 Million EUR , up 120.09% from previous quarter.
Lavipharm S.A. reported an annual EBITDA of 5.6 Million EUR in 2022, up 251.04% from previous year.
Lavipharm S.A. reported an annual EBITDA of 6.23 Million EUR in 2021, down -64.5% from previous year.
Lavipharm S.A. reported a quarterly EBITDA of N/A for 2023 FY, up 89.94% from previous quarter.
Lavipharm S.A. reported a quarterly EBITDA of 5.76 Million EUR for 2023 Q2, up 335.75% from previous quarter.

Annual EBITDA Chart of Lavipharm S.A. (2023 - 2016)

Historical Annual EBITDA of Lavipharm S.A. (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	9.86 Million EUR	89.94%
2022	5.6 Million EUR	251.04%
2021	6.23 Million EUR	-64.5%
2020	6.79 Million EUR	53.61%
2019	5.46 Million EUR	182.06%
2018	3.76 Million EUR	-76.07%
2017	17.09 Million EUR	314.76%
2016	19.73 Million EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	5.68 Million EUR	120.09%
2023 FY	- EUR	89.94%
2023 Q2	5.76 Million EUR	335.75%
2023 Q4	2.58 Million EUR	-55.2%
2022 Q2	1.87 Million EUR	601.61%
2022 FY	- EUR	251.04%
2022 Q4	1.32 Million EUR	-29.29%
2021 Q2	1.62 Million EUR	21.27%
2021 FY	- EUR	-64.5%
2021 Q4	-373 Thousand EUR	-122.95%
2020 FY	- EUR	53.61%
2020 Q4	1.34 Million EUR	-40.66%
2020 Q2	2.25 Million EUR	61.52%
2019 FY	- EUR	182.06%
2019 Q4	1.39 Million EUR	0.0%
2018 FY	- EUR	-76.07%
2017 FY	- EUR	314.76%
2016 FY	- EUR	0.0%

Peer EBITDA Comparison of Lavipharm S.A.

Name	EBITDA	EBITDA Difference